|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
CANCER ANTIGEN 125
Test CodeLAB155
Alias/See Also
CA125
OVARIAN CANCER ANTIGEN
OVARIAN CANCER ANTIGEN
CPT Codes
86304
Preferred Specimen
Green Top/Gel LiHep
Minimum Volume
2.0 mL
Transport Container
Li Heparin (GST)
Transport Temperature
Refrigerate specimen
Methodology
ECLIA
Setup Schedule
Set Up:Daily Report Available:1 day
Reference Range
Cancer antigen 125: | 2.1 - 35.0 U/mL |
Clinical Significance
Serum CA 125 assay values are useful for monitoring the course of disease in patients with invasive epithelial ovarian cancer. In a review of nine published studies, the overall correlation reported between CA 125 serum levels and the course of the disease was 87%. Persistently rising CA 125 assay values may be associated with malignant disease and poor response to therapy, whereas decreasing CA 125 assay values may indicate a favorable response to therapy. Elevations of CA 125 assay values have been reported in approximately 1-2% of healthy individuals, and in individuals with nonmalignant conditions such as cirrhosis, hepatitis, endometriosis, first trimester pregnancy, ovarian cysts, and pelvic inflammatory disease. Elevations of CA 125 assay values during the menstrual cycle have also been reported. Non-ovarian malignancies in which elevated CA 125 assay values have been reported include cervical, liver, pancreatic, lung, colon, stomach, biliary tract, uterine, fallopian tube, breast, and endometrial carcinomas. The CA 125 assay is not recommended as a screening procedure to detect cancer in the general population; however, use of the CA 125 assay as an aid in the management of ovarian cancer patients has been reported.
Performing Laboratory
GBMC Chemistry